Asgard Therapeutics Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
29
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$2.59M
- Investors
-
14
Asgard Therapeutics General Information
Description
Developer of cancer immunotherapeutic systems designed to provide direct cell reprogramming for cancer immunotherapy. The company builds reprogramming technologies to develop gene therapy products to set efficient and personalized immune responses in motion, enabling patients to acquire new forms of treatment for cancer resistant to conventional treatment methods.
Contact Information
Website
www.asgardthx.comCorporate Office
- Medicon Village
- Scheelevägen 2
- 223 81 Lund
- Sweden
Corporate Office
- Medicon Village
- Scheelevägen 2
- 223 81 Lund
- Sweden
Asgard Therapeutics Timeline
Asgard Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Grant | 22-Jan-2025 | $2.59M | Completed | Pre-Clinical Trials | ||
| 13. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
| 12. Later Stage VC (Series A) | 14-Mar-2024 | Completed | Pre-Clinical Trials | |||
| 11. Grant | 06-Mar-2024 | Completed | Pre-Clinical Trials | |||
| 10. Grant | 14-Apr-2023 | Completed | Startup | |||
| 9. Seed Round | 21-Nov-2021 | Completed | Startup | |||
| 8. Grant | 25-Oct-2021 | Completed | Startup | |||
| 7. Grant | 15-Apr-2021 | Completed | Startup | |||
| 6. Grant | 06-Apr-2020 | $110K | Completed | Startup | ||
| 5. Grant | 01-Dec-2019 | $55.3K | Completed | Startup |
Asgard Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Asgard Therapeutics Comparisons
Industry
Financing
Details
Asgard Therapeutics Competitors (2)
One of Asgard Therapeutics’s 2 competitors is Chosa Oncology, a Corporation company based in Malmo, Sweden.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Chosa Oncology | Corporation | Malmo, Sweden | ||||
| Cellevate | Venture Capital-Backed | Lund, Sweden |
Asgard Therapeutics Patents
Asgard Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026003069-A1 | Constructs and vectors for reprogramming cells to cdc1 cells, compositions and methods thereof | Pending | 25-Jun-2024 | ||
| WO-2026003071-A2 | Novel transcription factor combinations for immune cell reprogramming and related methods | Pending | 25-Jun-2024 | ||
| WO-2026003071-A3 | Novel transcription factor combinations for immune cell reprogramming and related methods | Pending | 25-Jun-2024 | ||
| WO-2026003067-A1 | Transcription factors and reprogramming modulators for reprogramming cells to cdc1 cells, compositions and methods thereof | Pending | 25-Jun-2024 | ||
| AU-2024392973-A1 | Rna-based strategies for dendritic cell reprogramming and uses thereof | Pending | 05-Dec-2023 | C12N5/0639 |
Asgard Therapeutics Signals
Asgard Therapeutics Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Johnson & Johnson JJDC | Corporate Venture Capital | Minority | ||
| RV Invest | Corporate Venture Capital | Minority | ||
| European Innovation Council | Accelerator/Incubator | |||
| Boehringer Ingelheim Venture Fund | Corporate Venture Capital | Minority | ||
| Industrifonden | Venture Capital | Minority |
Asgard Therapeutics FAQs
-
When was Asgard Therapeutics founded?
Asgard Therapeutics was founded in 2018.
-
Where is Asgard Therapeutics headquartered?
Asgard Therapeutics is headquartered in Lund, Sweden.
-
What is the size of Asgard Therapeutics?
Asgard Therapeutics has 29 total employees.
-
What industry is Asgard Therapeutics in?
Asgard Therapeutics’s primary industry is Biotechnology.
-
Is Asgard Therapeutics a private or public company?
Asgard Therapeutics is a Private company.
-
What is Asgard Therapeutics’s current revenue?
The current revenue for Asgard Therapeutics is .
-
How much funding has Asgard Therapeutics raised over time?
Asgard Therapeutics has raised $82.6M.
-
Who are Asgard Therapeutics’s investors?
Johnson & Johnson JJDC, RV Invest, European Innovation Council, Boehringer Ingelheim Venture Fund, and Industrifonden are 5 of 14 investors who have invested in Asgard Therapeutics.
-
Who are Asgard Therapeutics’s competitors?
Chosa Oncology and Cellevate are competitors of Asgard Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process